PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38 | -81.9% | 14,262 | -71.3% | 0.00% | -85.7% |
| Q4 2022 | $210 | -99.9% | 49,760 | +144.1% | 0.03% | +55.6% |
| Q2 2021 | $187,000 | +12.7% | 20,384 | +25.7% | 0.02% | 0.0% |
| Q4 2020 | $166,000 | +44.3% | 16,213 | +52.4% | 0.02% | +100.0% |
| Q3 2019 | $115,000 | -66.9% | 10,637 | -37.7% | 0.01% | -52.6% |
| Q4 2018 | $347,000 | -47.5% | 17,065 | +209.2% | 0.02% | -42.4% |
| Q3 2017 | $661,000 | – | 5,519 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |